| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Luís Gustavo Ramos de Moraes Calheiros, Giovana Pedro, Thayna Oliveira da Silva, Rogério Martins Amorim, Carlos Eduardo Fonseca Alves, Renée Laufer-Amori. In Vitro Antitumor Effect of Oils Rich in CBD and THC Cannabis Extract in Canine Prostate Carcinoma Cell Lines. Veterinary sciences. vol 11. issue 10. 2024-10-25. PMID:39453093. |
cannabidiol (cbd) and Δ9-tetrahydrocannabinol (thc) are the two main cannabinoids extracted from |
2024-10-25 |
2024-10-28 |
human |
| Heith Copes, Megan Webb, Jessica Valle. Contesting Cannabinoid Hyperemesis Syndrome: How Narratives of Cannabis Shape Diagnosis Contestation and Treatment Resistance. Qualitative health research. 2024-10-25. PMID:39455058. |
contesting cannabinoid hyperemesis syndrome: how narratives of cannabis shape diagnosis contestation and treatment resistance. |
2024-10-25 |
2024-10-29 |
human |
| Heith Copes, Megan Webb, Jessica Valle. Contesting Cannabinoid Hyperemesis Syndrome: How Narratives of Cannabis Shape Diagnosis Contestation and Treatment Resistance. Qualitative health research. 2024-10-25. PMID:39455058. |
cannabinoid hyperemesis syndrome (chs) is characterized by the onset of cyclic bouts of severe nausea and vomiting in chronic cannabis users. |
2024-10-25 |
2024-10-29 |
human |
| Driti Reechaye, Anne Laure Annaick Perrine, Yashil Jahajeeah, Fateema Dookhee, Jared Robinson, Indrajit Banerje. Cannabinoids as a Natural Alternative for the Management of Neuropathic Pain: A Systematic Review of Randomized Placebo-Controlled Trials. Cureus. vol 16. issue 9. 2024-10-24. PMID:39445260. |
recently, cannabinoids have emerged as an alternative and natural option for the treatment of chronic pain, with tetrahydrocannabinol (thc) and cannabidiol (cbd) being the most extensively studied neuroactive components. |
2024-10-24 |
2024-10-26 |
Not clear |
| Steven Didik, Oleg Palygin, Mark Chandy, Alexander Staruschenk. The effects of cannabinoids on the kidney. Acta physiologica (Oxford, England). 2024-10-24. PMID:39445706. |
cannabinoids are a class of drugs derived from the cannabis plant that are widely used for the treatment of various medical conditions and recreational use. |
2024-10-24 |
2024-10-26 |
Not clear |
| Matthew C Nali, Joshua S Yang, Zhuoran Li, Meng Zhen Larsen, Tim K Macke. Cannabis-Derived Product Types, Flavors, and Compound Types From an E-Commerce Website. JAMA network open. vol 7. issue 10. 2024-10-21. PMID:39432307. |
a classification of product and flavor types is necessary to establish a foundation for comparative research, although research aiming to classify cannabis in its variety of products, flavors, and cannabinoid compounds based on public online e-commerce data is lacking. |
2024-10-21 |
2024-10-23 |
Not clear |
| Maxwell C K Leung, Edward D Levi. Neurotoxicology and Public Health Issues of Cannabis and Cannabinoids. Neurotoxicology. 2024-10-21. PMID:39433220. |
neurotoxicology and public health issues of cannabis and cannabinoids. |
2024-10-21 |
2024-10-24 |
Not clear |
| Mahmoud A ElSohly, Chandrani G Majumdar, Suman Chandra, Mohammed M Radwa. A 10-year trend in cannabis potency (2013-2022) in different geographical regions of the United States of America. Frontiers in public health. vol 12. 2024-10-18. PMID:39421827. |
this report examines the concentration of cannabinoids in illicit cannabis samples seized by the united states drug enforcement administration (dea) over the last 10 years (2013-2022). |
2024-10-18 |
2024-10-20 |
Not clear |
| Gracesenia Chahyadinata, Joo Hyun Nam, Ashley Battenberg, Brian J Wainge. Physiological profiling of cannabidiol reveals profound inhibition of sensory neurons. Pain. 2024-10-16. PMID:38815194. |
cannabidiol (cbd), the main nonpsychoactive cannabinoid of cannabis, holds promise for nonaddictive treatment of pain. |
2024-10-16 |
2024-10-18 |
human |
| Mayur B Kale, Mohit D Umare, Nitu L Wankhede, Rohitas Deshmukh, Vikrant Abbot, Md Khalid Anwer, Brijesh G Taksande, Aman B Upaganlawar, Milind J Umekar, Seema Ramniwas, Monica Gulati, Rashmi Arora, Tapan Beh. Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders. Current pharmaceutical design. 2024-10-16. PMID:39410886. |
decoding the therapeutic potential of cannabis and cannabinoids in neurological disorders. |
2024-10-16 |
2024-10-18 |
Not clear |
| Mayur B Kale, Mohit D Umare, Nitu L Wankhede, Rohitas Deshmukh, Vikrant Abbot, Md Khalid Anwer, Brijesh G Taksande, Aman B Upaganlawar, Milind J Umekar, Seema Ramniwas, Monica Gulati, Rashmi Arora, Tapan Beh. Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders. Current pharmaceutical design. 2024-10-16. PMID:39410886. |
the evolving landscape of cannabis research presents exciting possibilities for developing targeted interventions that capitalize on the neuroprotective benefits of cannabinoids while navigating the complexities of receptor specificity and clinical applicability. |
2024-10-16 |
2024-10-18 |
Not clear |
| Daniel Stjepanović, Julia Kirkam, Wayne Hal. Rare but relevant: Cannabinoid hyperemesis syndrome. Addiction (Abingdon, England). 2024-10-15. PMID:39402864. |
cannabinoid hyperemesis syndrome (chs) is a (probably) rare syndrome that occurs in frequent and chronic cannabis users. |
2024-10-15 |
2024-10-17 |
Not clear |
| Roman Paduch, Katarzyna Szwaczko, Kamil Dziuba, Adrian Wiate. Exploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells. Cells. vol 13. issue 19. 2024-10-15. PMID:39404380. |
in the present study, we obtained cannabinoids, such as cannabidiol (cbd), abnormal cannabigerol (abn-cbg), cannabichromene (cbc), and cannabicitran (cbt), by chemical synthesis and performed the biological evaluation of their activity on colon cancer cells. |
2024-10-15 |
2024-10-17 |
human |
| Qiandai Shi, Qi Wu, Qiqi Wang, Song Zhu, Maoyue Guo, Yongmei Xi. Cannabidiol Finds Dihydrocannabidiol as Its Twin in Anti-Inflammatory Activities and the Mechanism. Journal of ethnopharmacology. 2024-10-10. PMID:39389390. |
the hemp (cataloged at the "medicinal plant names services" as cannabis sativa l.) extracts, cannabinoids have been used for centuries in southeast asia as folk medicines and now authorized by about 50 countries for application in medicine, health care products and cosmetics. |
2024-10-10 |
2024-10-13 |
Not clear |
| Qiandai Shi, Qi Wu, Qiqi Wang, Song Zhu, Maoyue Guo, Yongmei Xi. Cannabidiol Finds Dihydrocannabidiol as Its Twin in Anti-Inflammatory Activities and the Mechanism. Journal of ethnopharmacology. 2024-10-10. PMID:39389390. |
as the most consumed cannabinoid, cannabidiol (cbd) has been recognized due to its various bioactivities, including anti-inflammatory and antibacterial properties. |
2024-10-10 |
2024-10-13 |
Not clear |
| Ai Kuzumi, Asako Yoshizaki-Ogawa, Takemichi Fukasawa, Shinichi Sato, Ayumi Yoshizak. The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review. American journal of clinical dermatology. 2024-10-05. PMID:39369127. |
cannabidiol (cbd) is a non-psychotropic cannabinoid with multiple pharmacological properties. |
2024-10-05 |
2024-10-08 |
Not clear |
| Varun Singh, Samar Vihal, Rupali Rana, Charul Rathor. Nanocarriers for Cannabinoid Delivery: Enhancing Therapeutic Potential. Recent advances in drug delivery and formulation. vol 18. issue 4. 2024-10-02. PMID:39356097. |
however, the complexity of cannabis components, especially cannabinoids, poses a challenge to effective medicinal administration. |
2024-10-02 |
2024-10-04 |
Not clear |
| b' \\xc3\\x81gnes T\\xc3\\xb3saki, Zsuzsanna Szab\\xc3\\xb3, J\\xc3\\xb3zsef Kir\\xc3\\xa1ly, Eszter Bogl\\xc3\\xa1rka L\\xc5\\x91rincz, Vir\\xc3\\xa1g Vass, Bence T\\xc3\\xa1nczos, Ilona Bereczki, P\\xc3\\xa1l Herczegh, \\xc3\\x89va Remenyik, \\xc3\\x81rp\\xc3\\xa1d T\\xc3\\xb3saki, Erzs\\xc3\\xa9bet Szab\\xc3\\xb. A new cannabigerol derivative, LE-127/2, induces autophagy mediated cell death in human cutaneous melanoma cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2024-10-02. PMID:39357769.' |
the ongoing investigation of natural antitumor agents, the nonpsychoactive cannabinoid, cannabigerol (cbg) found in cannabis sativa is emerging as a promising candidate. |
2024-10-02 |
2024-10-05 |
human |
| L Cinnamon Bidwell, Renee Martin-Willett, Samantha N Melendez, Luiza Rosa, Gregory Giordano, Kent E Hutchison, Angela D Brya. LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder. PloS one. vol 19. issue 9. 2024-09-30. PMID:39348366. |
some research has found that the non-intoxicating cannabinoid cannabidiol reduces cannabis use and cannabis use disorder-related symptoms, such as affective disturbance and withdrawal. |
2024-09-30 |
2024-10-03 |
Not clear |
| Zhe Yang, Li-Wei Jiang, Si-Yao Yang, Yi-di Wu, Jian-Xia Ly. [Simultaneous determination of 102 synthetic cannabinoids in electronic cigarette oil by liquid chromatography-tandem mass spectrometry]. Se pu = Chinese journal of chromatography. vol 42. issue 10. 2024-09-27. PMID:39327658. |
synthetic cannabinoids (scs), which are among the most widely abused new psychoactive substances, are much more potent and have greater efficacy than natural cannabis. |
2024-09-27 |
2024-09-29 |
Not clear |